Back to catalog

MSPInstruments
Next Generation Impactor (NGI)
NGI cascade impactor, the industry-standard pharmaceutical device adopted by USP guidelines for in vitro particle size testing of inhalers.
Prices and availability are quoted by email or phone.
The NGI has been the industry-standard pharmaceutical cascade impactor for the past 20 years, with more than 1,800 units in use and adopted by USP guidelines. It was designed and developed by and for the OINDP industry, and is the most efficient and accurate way to perform standard in vitro APSD testing. Numerous automated and semi-automated add-ons, as well as other accessories, are available to further improve efficiency.
Applications
- Dry powder inhaler (DPI) testing
- Metered dose inhaler (MDI) testing
- Soft mist inhaler (SMI) testing
- Nebulizer testing
- Inhalation drug formulation development
- Respiratory drug delivery research
- Particle size distribution measurement in dry powder inhalers (OINDP)
- Generic inhaler development
- Quality control for inhalation products





